Four-year data from the Zilver PTX Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease from Cook Medical presented today at the 2013 Vascular Interventional Advances (VIVA) meeting demonstrates 75 percent...
As medical device sizes shrink, their designs increasingly push the limits of feature complexity and material properties. Advances in fabrication technologies must keep pace with the demands of cost-effectively manufacturing these increasingly micro-scale, sophisticated devices.
The FDA published the final rule for the unique device identification system (UDI) during the UDI Conference in Baltimore, MD and released it on September 24, 2013. This much anticipated rule will provide a consistent way to identify medical devices and ensure that proper safety regulations are being followed.
When Qiaobing Xu was named an assistant professor of biomedical engineering at Tufts in 2010, his first goal was to find a research niche to make his mark in. He soon came up with a literally cutting-edge concept: whittling wood. Wood, he explains...
Terumo Interventional Systems has announced the nationwide availability of the AZUR® CX Peripheral Coil System, the first and only peripheral embolization coil designed to provide cross‐sectional coverage incorporating the benefits of...
In elementary school we were all taught the scientific method. The part many of us disliked the most came after testing and analyzing the results of an experiment only to find out our hypothesis was wrong and we had to do the testing all over again.
NuVasive Inc. introduced a new implant to be used with its XLIF spinal fusion procedure in the U.S., the XLIF Decade plate. The device is designed to provide surgeons with an option for a single-approach XLIF (eXtreme Lateral Interbody Fusion), NuVasive's alternative to traditional spinal fusion procedures.
What sounds like a dream of the future has already been the subject of research for a few years: simply printing out tissue and organs. Now scientists have further refined the technology and are able to produce various tissue types.
NuVasive, Inc., a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce the domestic launch of the XLIF Decade Plate. The XLIF Decade Plate is the Company's latest advancement in providing surgeon customers with an option for a single-approach XLIF® and fixation.
U.K.-based medical device maker Lombard Medical Technologies is doubling down on its flagship Aorfix aortic stent graft technology, dumping its non-core businesses and expanding facilities to meet demand for the device. Lombard is broadening its R&D and manufacturing facilities in Dicot, Oxfordshire...
FDA Grants Prestigious Award to Pediatric Medical Device Consortium Led by Children’s Hospital Los AngelesOctober 1, 2013 3:52 pm | by Business Wire | News | Comments
The U.S. Food and Drug Administration’s Office of Orphan Products Development has awarded a grant of up to $1.5 million over five years to the Southern California Center of Technology and Innovation in Pediatrics (CTIP), a consortium established by Children’s Hospital Los Angeles and the University of Southern California (USC) for the development of pediatric medical devices.
One day, I envision that there will be medical technology that can exceed the capabilities of the human body’s natural physiology. Should someone with such a device be prevented from playing professional sports due to the competitive advantage it provides?
Drug delivery coatings are not a new technology to the medical device industry. However, as more implantable devices are tasked with achieving a greater level of healthcare, they do offer great benefit to design engineers. This article reviews drug coating technology and looks at application areas where it has made a significant impact.
Biotronik is beginning the launch of its newly approved Ilesto line of thinner, smaller cardiac implants with the remotely monitored Ilesto DX platform, the company announced today. The Ilesto line of implants is 15% smaller and requires 29% fewer components than its predecessors, Biotronik said...
Intact Vascular Announces Completion of Enrollment of the Tack Optimized Balloon Angioplasty (TOBA) StudyOctober 1, 2013 11:44 am | by Business Wire | News | Comments
Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the completion of enrollment of the Tack Optimized Balloon Angioplasty (TOBA) study. The purpose of this multi-center study is to gather confirmatory data on the use of the Tack-It Endovascular System™ in the superficial femoral and popliteal arteries.
BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced it has received approval from the Food and Drug Administration (FDA) for its Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices).
Micell Technologies, Inc. has entered into an agreement with Hefei Life Science Technology Park Investment and Development Co., Ltd. (Hefei Life Science), for the clinical development, marketing and distribution of the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent...
Vertebral Technologies, Inc. (VTI) is pleased to announce the InterFuse Lateral (InterFuse L™) a modular lateral lumbar interbody fusion device has received 510(k) clearance from the FDA. The InterFuse L™ uses VTI’s patented modular insertion technique to provide a large lateral footprint through a significantly smaller lateral access channel.
Implants made of biocompatible material will help heal soldiers wounded in the battlefield and civilians as well through research at Rice University and The University of Texas Health Science Center at Houston. The implants hold open a space for a more permanent repair.
A $75 million Department of Defense grant to improve technologies to treat soldiers injured on the battlefield and advance care for the public will involve bioengineers at Rice University and the University of Texas Health Science Center at Houston (UTHealth).
Cochlear Launches the Nucleus® 6 Sound Processor in the United States -- Simply Smarter in Every Hearing SituationSeptember 30, 2013 11:00 am | by PR Newswire | News | Comments
Cochlear Limited, the global leader in implantable hearing solutions, announced today the commercial availability of the Nucleus® 6 Sound Processor in the United States. Nucleus 6, the next generation cochlear implant sound processor for Cochlear, is built on a completely new microchip platform with five times the processing power of the market-leading Nucleus 5 System.
A new Nanoimprint Foundry, led by Singapore A*STAR's Institute of Materials Research and Engineering (IMRE), will bridge the gap between laboratory-based nanotechnologies and real-world products. The pioneer initiative brings together...
FDA Rule Mandating Unique Device Identification for Reusable Medical Devices Creates New Market Opportunity for VeriTeQ in Breast Implant Sizers and Other Reprocessed DevicesSeptember 30, 2013 8:30 am | by Business Wire | News | Comments
Digital Angel Corporation, a provider of implantable medical device identification and radiation dose measurement technologies, following its recent share exchange with VeriTeQ Acquisition Corporation, discussed today a new market opportunity for identifying breast implant sizers, which was created, in part, by the FDA Final Rule for Unique Device Identification, announced on September 20, 2013.
Intersect ENT Announces Positive Results from Pilot Study of Novel In-Office Implant for Chronic Sinusitis PatientsSeptember 30, 2013 8:05 am | by Business Wire | News | Comments
Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and their patients, today reported findings from a prospective U.S. multi-center pilot study to evaluate the feasibility, safety and efficacy of the company’s newest steroid delivery implant for patients suffering from the debilitating symptoms of chronic sinusitis.
All interested parties are welcome to join in the development of a proposed new ASTM International standard that will provide guidance on how to conduct axial, bending and torsional fatigue testing of stents. The proposed new standard, ASTM WK23330, Guide for in Vitro Axial, Bending and Torsional Durability Testing of Vascular Stents...